Avantor, Inc. (AVTR)
15.44
-0.38
(-2.37%)
USD |
NYSE |
Oct 06, 16:00
15.48
+0.04
(+0.29%)
After-Hours: 19:48
Avantor Cash from Investing (Quarterly) : -37.30M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -37.30M |
| March 31, 2026 | -32.70M |
| December 31, 2025 | -39.70M |
| September 30, 2025 | -33.30M |
| June 30, 2025 | -28.60M |
| March 31, 2025 | -28.90M |
| December 31, 2024 | 558.50M |
| September 30, 2024 | -40.50M |
| June 30, 2024 | -44.90M |
| March 31, 2024 | -34.20M |
| December 31, 2023 | -50.00M |
| September 30, 2023 | -37.00M |
| June 30, 2023 | -29.40M |
| March 31, 2023 | -27.30M |
| December 31, 2022 | -33.10M |
| September 30, 2022 | 4.10M |
| June 30, 2022 | -41.10M |
| Date | Value |
|---|---|
| March 31, 2022 | -39.50M |
| December 31, 2021 | -2.884B |
| September 30, 2021 | -34.30M |
| June 30, 2021 | -1.189B |
| March 31, 2021 | -14.60M |
| December 31, 2020 | -18.80M |
| September 30, 2020 | -15.90M |
| June 30, 2020 | -12.50M |
| March 31, 2020 | -11.90M |
| December 31, 2019 | -11.40M |
| September 30, 2019 | -10.40M |
| June 30, 2019 | -12.40M |
| March 31, 2019 | -7.90M |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | -7.20M |
| March 31, 2018 | -11.80M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Medpace Holdings, Inc. | -23.88M |
| Champions Oncology, Inc. | -0.055M |
| Personalis, Inc. | 38.16M |
| Adaptive Biotechnologies Corp. | -43.48M |
| 10X Genomics, Inc. | -7.735M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 178.20M |
| Cash from Financing (Quarterly) | -112.40M |
| Free Cash Flow | 454.70M |
| Free Cash Flow Per Share (Quarterly) | 0.2076 |
| Free Cash Flow to Equity (Quarterly) | 259.10M |
| Free Cash Flow to Firm (Quarterly) | 164.72M |
| Free Cash Flow Yield | 4.34% |